Community Research and Development Information Service - CORDIS

Future Formulations: Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral Exchange

From 2016-04-01 to 2020-03-31, ongoing project

Project details

Total cost:

EUR 414 000

EU contribution:

EUR 414 000

Coordinated in:

United Kingdom

Call for proposal:

H2020-MSCA-RISE-2015See other projects for this call

Funding scheme:

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Objective

Related Information not available

Deliverables

  • Generation of ISO 1345 Quality Management System

    This deliverable will be acheived through secondments at Hy2Care which will focus on activities associated with product manufacture. Although product manufacture under cGMP conditions will be outsourced, the secondee(s) will be required to develop an ISO13485 quality management system to underpin this activity.

  • Standardized protocols for the formulation of nanoparticles with defined properties

    This deliverable will be achieved through: Task 4.1 - the production and in vitro performance testing of a range of nanoparticle delivery systems (containing vitamin A) Task 4.2 - Characterisation of the resulting nanoparticulate formulations by AFM, ToF-SIMS, SEM and other analysis techniques.

  • Standardized SOPs for the optimized isolation of different cell types

    This deliverable will be acheived by : Task 2.1 - optimization of primary and stem cell isolation protocols from tissues (e.g. adipose derived stem cells, cardiomyocytes, chondrocytes, osteoblasts, hepatocytes, pancreatic islets and fibroblasts) using formulations of specific collagenase class I/II ratios and of protease amount/type (thermolysin, dispase, pronase); Task 2.2 – evaluation of new biomarine enzyme formulations currently under development at Abiel; Task 2.3 – assessment of the reproducibility of results (e.g. cell yield, viability and functionality) and comparison to current standard isolation procedures (e.g. via commercial competitor products).

  • FutForm Website up and running

    The Coordinator will set up a website to support documentation for each secondment undertaken and dissemination of the resultant activities. The coordinator will also ensure the FutForm website provides up to date information regarding secondments (practicalities, outcomes, documentation etc) and training opportunities.

  • Consortium agreement signed

    This deliverable will be achieved as follows: Task 1: The coordinator will ensure all partners are aware of FutForm operational management requirements. Task 3: Compilation, collation and distribution of consortium documentation. The coordinator (assisted by the FutForm project manager) will be responsible for the compilation, collation and distribution of all consortium documentation in relation to operational management and in particular the research secondments.

Publications

Coordinator

THE UNIVERSITY OF NOTTINGHAM
United Kingdom

EU contribution: EUR 297 000


University Park
NG7 2RD NOTTINGHAM
United Kingdom
Activity type: Higher or Secondary Education Establishments

Contact the organisation

Participants

INOVAPOTEK, PHARMACEUTICAL RESEARCH AND DEVELOPMENT LDA
Portugal

EU contribution: EUR 36 000


UPTEC - RUA ALFREDO ALLEN 455/461
4200-135 PORTO
Portugal
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

HY2CARE BV
Netherlands

EU contribution: EUR 54 000


HENGELOSESTRAAT 511
7521 AG ENSCHEDE
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

ABIEL SOCIETA A RESPONSABILITA LIMITATA
Italy

EU contribution: EUR 27 000


VIALE DELLE SCIENZE SN
90128 PALERMO
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top